 DURHAM, N.C., Aug. 01, 2022 GLOBE NEWSWIRE -- Chimerix NASDAQ:CMRX, a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend lives of patients facing deadly diseases, today announced that it will host a live conference call and audio webcast on Monday, August 8, 2022 at 4:30 p.m. ET to report financial results for the second quarter ended June 30, 2022, and to provide a business overview. 